All our recent case studies
Do your part
Cities
Programmes
Find NIHR BioResource approved studies based on area of study, type of study (participant recall, samples and data, data only) and active state.
For detailed information on specific data see https://bioresourcesupport.org.uk/genetic-data-from-snp-chips-arrays/
Studies 19-27 of 235
How do white blood cells destroy the insulin producing cells in Type 1 Diabetes
Speciality areaDiabetes
Study typeParticipant re-contact
Researcher typeAcademic
Research leadDr Ania Skowera
Genetic Variation AND Altered Leucocyte Function in health and disease (GANDALF)
Speciality areaCross-cutting, Haematology
Research leadProfessor Ken Smith
A study of the long-term safety and mechanism of action of alemtuzumab, an experimental drug used in Multiple Sclerosis
Speciality areaNeurological Disorders
Research leadDr. Anu Kemppinen
Adaptive study of the dose of the drug aldesleukin (interleukin-2) on regulatory T cells in type 1diabetes (DILT1D)
Research leadDr Frank Waldron-Lynch
A study of molecules from the gut (chemokines) and their role in the development of Primary Sclerosing Cholangitis, Inflammatory Bowel Disease or Colorectal Cancer
Speciality areaLiver
Research leadDr.Gideon Hirschfield
Genetic Variation and Altered Leucocyte Function in Health and Disease
Speciality areaCross-cutting
Investigate the autoantibody response to a novel drug (GSK2862277) and their effect on TNFR1 activation
Speciality areaInfection
Study typeSamples and data
Researcher typeCommercial
Research leadDr Andrew Bayliffe
CAtion leakage from RED cells (CARED)
Speciality areaHaematology
Research leadDr Rebecca Cardigan
Biological Mechanism of Inflammatory Bowel Disease Affected by Genetic Variation
Speciality areaGastroenterology
Research leadProfessor Arthur Kaser